• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脑靶向 vgf 基因治疗的脂质体纳米粒的体外和体内优化。

In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy.

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo 58105, ND, USA.

Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo 58105, ND, USA.

出版信息

Int J Pharm. 2021 Oct 25;608:121095. doi: 10.1016/j.ijpharm.2021.121095. Epub 2021 Sep 20.

DOI:10.1016/j.ijpharm.2021.121095
PMID:34543617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8574129/
Abstract

Vgf (non-acronymic), a neurotrophin stimulated protein which plays a crucial role in learning, synaptic activity, and neurogenesis, is markedly downregulated in the brain of Alzheimer's disease (AD) patients. However, since vgf is a large polar protein, a safe and efficient gene delivery vector is critical for its delivery across the blood brain barrier (BBB). This research work demonstrates brain-targeted liposomal nanoparticles optimized for delivering plasmid encoding vgf across BBB and transfecting brain cells. Brain targeting was achieved by surface functionalization using glucose transporter-1 targeting ligand (mannose) and brain targeted cell-penetrating peptides (chimeric rabies virus glycoprotein fragment, rabies virus derived peptide, penetratin peptide, or CGNHPHLAKYNGT peptide). The ligands were conjugated to lipid via nucleophilic substitution reaction resulting in >75% binding efficiency. The liposomes were formed by film hydration technique demonstrating size <200 nm, positive zeta potential (15-20 mV), and polydispersity index <0.3. The bifunctionalized liposomes demonstrated ∼3 pg/µg protein vgf transfection across in vitro BBB, and ∼80 pg/mg protein in mice brain which was 1.5-2 fold (p < 0.05) higher compared to untreated control. The nanoparticles were also biocompatible in vitro and in vivo, suggesting a safe and efficient gene delivery system to treat AD.

摘要

Vgf(非首字母缩写词)是一种神经营养因子刺激蛋白,在学习、突触活动和神经发生中起着至关重要的作用,在阿尔茨海默病(AD)患者的大脑中显著下调。然而,由于 vgf 是一种大型极性蛋白,因此安全有效的基因传递载体对于其穿过血脑屏障(BBB)至关重要。这项研究工作展示了经过优化的脑靶向脂质体纳米颗粒,可用于将编码 vgf 的质粒递送到 BBB 并转染脑细胞。通过使用葡萄糖转运蛋白-1 靶向配体(甘露糖)和脑靶向细胞穿透肽(嵌合狂犬病病毒糖蛋白片段、狂犬病病毒衍生肽、穿透肽或 CGNHPHLAKYNGT 肽)进行表面功能化来实现脑靶向。配体通过亲核取代反应与脂质结合,结合效率>75%。通过薄膜水化技术形成脂质体,其粒径<200nm,正zeta 电位(15-20mV),多分散指数<0.3。双功能化脂质体在体外 BBB 中显示出3pg/μg 蛋白 vgf 转染,在小鼠脑中为80pg/mg 蛋白,与未处理的对照组相比提高了 1.5-2 倍(p<0.05)。该纳米颗粒在体外和体内也具有生物相容性,表明这是一种安全有效的基因传递系统,可用于治疗 AD。

相似文献

1
In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy.基于脑靶向 vgf 基因治疗的脂质体纳米粒的体外和体内优化。
Int J Pharm. 2021 Oct 25;608:121095. doi: 10.1016/j.ijpharm.2021.121095. Epub 2021 Sep 20.
2
ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles.载转铁蛋白和穿透肽修饰的脂纳米粒靶向 ApoE-2 的脑内基因治疗。
Pharm Res. 2019 Sep 16;36(11):161. doi: 10.1007/s11095-019-2691-7.
3
Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease.载脂蛋白 E2 基因递释系统的设计与验证:用于逃避血脑屏障以有效治疗阿尔茨海默病。
Mol Pharm. 2021 Feb 1;18(2):714-725. doi: 10.1021/acs.molpharmaceut.0c00461. Epub 2020 Sep 16.
4
GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier.GLUT-1:血脑屏障通透性脑源性神经营养因子基因传递的有效靶点。
ACS Chem Neurosci. 2020 Jun 3;11(11):1620-1633. doi: 10.1021/acschemneuro.0c00076. Epub 2020 May 12.
5
Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.脑靶向脂质纳米粒的构建与筛选及其增强的细胞穿透和基因传递性能。
Int J Nanomedicine. 2019 Aug 14;14:6497-6517. doi: 10.2147/IJN.S215941. eCollection 2019.
6
Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.神经生长因子基因经血脑屏障递送至减少 AD 小鼠β淀粉样蛋白沉积。
Mol Pharm. 2020 Jun 1;17(6):2054-2063. doi: 10.1021/acs.molpharmaceut.0c00218. Epub 2020 Apr 30.
7
Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.双修饰脂质体用于靶向增强小鼠脑内基因传递。
J Pharmacol Exp Ther. 2020 Sep;374(3):354-365. doi: 10.1124/jpet.119.264127. Epub 2020 Jun 19.
8
Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimer's disease pathology in transgenic mouse model.用于脑靶向 BDNF 基因治疗的功能化纳米颗粒,以挽救转基因小鼠模型中的阿尔茨海默病病理。
Int J Biol Macromol. 2022 May 31;208:901-911. doi: 10.1016/j.ijbiomac.2022.03.203. Epub 2022 Apr 2.
9
Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes.使用狂犬病毒糖蛋白(RVG)和转铁蛋白共轭脂质体进行高效神经元靶向和转染。
Brain Res. 2020 May 1;1734:146738. doi: 10.1016/j.brainres.2020.146738. Epub 2020 Feb 17.
10
Multifunctionalized Cationic Chitosan Polymeric Micelles Polyplexed with pVGF for Noninvasive Delivery to the Mouse Brain through the Intranasal Route for Developing Therapeutics for Alzheimer's Disease.多功能阳离子壳聚糖聚合物胶束与 pVGF 复合,通过鼻腔途径非侵入性递送至小鼠脑内,用于开发治疗阿尔茨海默病的疗法。
Mol Pharm. 2023 Jun 5;20(6):3009-3019. doi: 10.1021/acs.molpharmaceut.3c00031. Epub 2023 Apr 24.

引用本文的文献

1
Mannosylated fisetin/carveol lipid nanocapsules: brain-targeted dual therapy for modulation of epileptogenesis and cognitive deficits.甘露糖基化漆黄素/香芹酚脂质纳米囊泡:用于调控癫痫发生和认知缺陷的脑靶向双重疗法
Drug Deliv Transl Res. 2025 Aug 9. doi: 10.1007/s13346-025-01937-2.
2
Dual-modified Liposomes Encapsulating Nucleic Acids (pApoE2 or pGFP) for Transport Studies Across a Hydrocortisone-enhanced In Vitro Blood-brain Barrier Model for CNS Therapeutic Screening.用于跨氢化可的松增强的体外血脑屏障模型进行中枢神经系统治疗筛选转运研究的双修饰脂质体(包裹核酸(pApoE2或pGFP))
Pharm Res. 2025 Aug;42(8):1331-1345. doi: 10.1007/s11095-025-03900-9. Epub 2025 Jul 28.
3

本文引用的文献

1
A review of the tortuous path of nonviral gene delivery and recent progress.非病毒基因递送的曲折道路及近期进展述评。
Int J Biol Macromol. 2021 Jul 31;183:2055-2073. doi: 10.1016/j.ijbiomac.2021.05.192. Epub 2021 Jun 1.
2
Improved insulin sensitivity in obese-diabetic mice via chitosan Nanomicelles mediated silencing of pro-inflammatory Adipocytokines.壳聚糖纳米胶束介导的促炎脂肪细胞因子沉默改善肥胖型糖尿病小鼠胰岛素敏感性。
Nanomedicine. 2021 Apr;33:102357. doi: 10.1016/j.nano.2020.102357. Epub 2021 Jan 15.
3
Smart Thermosensitive Copolymer Incorporating Chitosan-Zinc-Insulin Electrostatic Complexes for Controlled Delivery of Insulin: Effect of Chitosan Chain Length.
Blood-Brain Barrier-Penetrating Nanocarriers Enable Microglial-Specific Drug Delivery in Hypothalamic Neuroinflammation.
血脑屏障穿透性纳米载体可实现下丘脑神经炎症中对小胶质细胞的特异性药物递送。
Adv Healthc Mater. 2025 May;14(13):e2500521. doi: 10.1002/adhm.202500521. Epub 2025 Apr 3.
4
Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies.推进中枢神经系统治疗:通过基于纳米颗粒的基因和酶替代疗法改善神经系统疾病。
Int J Nanomedicine. 2025 Feb 4;20:1443-1490. doi: 10.2147/IJN.S457393. eCollection 2025.
5
Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.利用纳米技术克服中枢神经系统疾病中的血脑屏障。
Mater Today Bio. 2025 Jan 4;31:101457. doi: 10.1016/j.mtbio.2025.101457. eCollection 2025 Apr.
6
Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy.阿尔茨海默病治疗方法的演变:从传统药物到药用植物、免疫疗法、微生物疗法和纳米疗法。
Pharmaceutics. 2025 Jan 17;17(1):128. doi: 10.3390/pharmaceutics17010128.
7
Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 and in Mice.转铁蛋白与细胞穿透肽功能化脂质体纳米粒的合成与表征及其在小鼠体内递送质粒ApoE2的研究
Mol Pharm. 2025 Jan 6;22(1):229-241. doi: 10.1021/acs.molpharmaceut.4c00870. Epub 2024 Dec 12.
8
Nanomedicine in the treatment of Alzheimer's disease: bypassing the blood-brain barrier with cutting-edge nanotechnology.纳米医学在阿尔茨海默病治疗中的应用:利用前沿纳米技术突破血脑屏障
Neurol Sci. 2025 Apr;46(4):1489-1507. doi: 10.1007/s10072-024-07871-4. Epub 2024 Dec 6.
9
Involvement of the VGF/BDNF axis in the neuropathology of Alzheimer's disease and its potential role in diagnosis and treatment.VGF/BDNF轴在阿尔茨海默病神经病理学中的作用及其在诊断和治疗中的潜在作用。
Rev Neurosci. 2024 Nov 19;36(3):267-278. doi: 10.1515/revneuro-2024-0110. Print 2025 Apr 28.
10
Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer's disease.用于将核酸递送至大脑以治疗阿尔茨海默病的功能化纳米颗粒。
Front Pharmacol. 2024 May 24;15:1405423. doi: 10.3389/fphar.2024.1405423. eCollection 2024.
用于胰岛素控释的含壳聚糖-锌-胰岛素静电复合物的智能热敏共聚物:壳聚糖链长的影响
Int J Polym Mater. 2020;69(16):1054-1068. doi: 10.1080/00914037.2019.1655750. Epub 2019 Aug 26.
4
Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease.载脂蛋白 E2 基因递释系统的设计与验证:用于逃避血脑屏障以有效治疗阿尔茨海默病。
Mol Pharm. 2021 Feb 1;18(2):714-725. doi: 10.1021/acs.molpharmaceut.0c00461. Epub 2020 Sep 16.
5
Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.双修饰脂质体用于靶向增强小鼠脑内基因传递。
J Pharmacol Exp Ther. 2020 Sep;374(3):354-365. doi: 10.1124/jpet.119.264127. Epub 2020 Jun 19.
6
In vitro and in vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA.CPP 和转铁蛋白修饰的脂质体包载 pDNA 的体外和体内特性研究。
Nanomedicine. 2020 Aug;28:102225. doi: 10.1016/j.nano.2020.102225. Epub 2020 May 30.
7
GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier.GLUT-1:血脑屏障通透性脑源性神经营养因子基因传递的有效靶点。
ACS Chem Neurosci. 2020 Jun 3;11(11):1620-1633. doi: 10.1021/acschemneuro.0c00076. Epub 2020 May 12.
8
Treatment of insulin resistance in obesity-associated type 2 diabetes mellitus through adiponectin gene therapy.通过脂联素基因治疗肥胖相关 2 型糖尿病的胰岛素抵抗。
Int J Pharm. 2020 Jun 15;583:119357. doi: 10.1016/j.ijpharm.2020.119357. Epub 2020 Apr 22.
9
Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.神经生长因子基因经血脑屏障递送至减少 AD 小鼠β淀粉样蛋白沉积。
Mol Pharm. 2020 Jun 1;17(6):2054-2063. doi: 10.1021/acs.molpharmaceut.0c00218. Epub 2020 Apr 30.
10
Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances.纳米载体作为治疗神经退行性疾病中克服血脑屏障的有力工具:聚焦于近期进展
Asian J Pharm Sci. 2019 Sep;14(5):480-496. doi: 10.1016/j.ajps.2018.09.005. Epub 2018 Oct 22.